Provided by Tiger Fintech (Singapore) Pte. Ltd.

Core Scientific, Inc.

6.63
+0.04000.61%
Post-market: 6.56-0.0662-1.00%19:46 EDT
Volume:9.75M
Turnover:63.49M
Market Cap:1.96B
PE:-1.51
High:6.75
Open:6.64
Low:6.30
Close:6.59
Loading ...
Jul 12, 2024

Major Issues Report

Form 8-K - Current report
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jul 05, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Proposed Sale Of Securities

Form144|Core Scientific's Officer Todd M.Duchene proposes to sell 7321 Shares, with a total value of approximately $68,714.91.
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form144|Core Scientific's Officer Todd M.Duchene proposes to sell 26230 Shares, with a total value of approximately $259,562.92.
Jun 14, 2024

Proposed Sale Of Securities

Form144|Core Scientific's Officer Todd M.Duchene proposes to sell 3770 Shares, with a total value of approximately $37,670.97.
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Major Issues Report

Form 8-K - Current report
May 21, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 06, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 30, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 29, 2024

Correspondence

Form CORRESP - Correspondence